Literature DB >> 18474684

Autoregulation of McA-RH7777 hepatoma cell proliferation by histamine H3 receptors.

E Davenas1, A Rouleau, S Morisset, J M Arrang.   

Abstract

Previous studies have suggested that histamine (HA) acts as an autocrine growth factor. We have explored the modulation of cell proliferation by HA using McA-RH7777 hepatoma cells. High L-histidine decarboxylase (HDC) expression and HA synthesis were found in McA-RH7777 cells. Whereas extracellular HA reached submicromolar concentrations, intracellular levels were very low, indicating that HA was secreted by the cells. McA-RH7777 cells also express H3-receptor (H3R) transcripts and proteins. Reverse transcriptase-polymerase chain reaction analysis detected only transcripts for the long isoform. Immunocytochemistry performed with a selective H3R antibody showed that most cells were immunoreactive. H3R binding sites (Bmax approximately 30 fmol/mg protein) were identified when [125I] iodoproxyfan binding was displaced by the agonist imetit. High-affinity binding also occurred at cytochrome P450 enzymes. This binding was not inhibited by HA, H3R agonists, or by a nonimidazole H3R antagonist but was displaced by imidazole H3R antagonists or by ketoconazole, a imidazole-containing cytochrome inhibitor. HA inhibited proliferation of McA-RH7777 hepatoma cells. The absence of uptake system, its much higher potency at H3Rs, and its low intracellular levels suggested that HA interacted with H3Rs rather than cytochromes. In agreement, both imidazole H3R antagonists, a nonimidazole H3R antagonist, and the HDC inhibitor alpha-monofluoromethyl histidine increased cell proliferation (up to approximately 60%), revealing a H3R-mediated inhibition by endogenous HA. Moreover, exogenous HA inhibited the increase induced by alpha-FMH or H3R antagonists with a nanomolar potency. In conclusion, our findings show that HA regulates proliferation of McA-RH7777 hepatoma cells by interacting with autoinhibitory H3Rs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474684     DOI: 10.1124/jpet.107.135368

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Histamine and histamine receptor regulation of gastrointestinal cancers.

Authors:  Lindsey Kennedy; Kyle Hodges; Fanyin Meng; Gianfranco Alpini; Heather Francis
Journal:  Transl Gastrointest Cancer       Date:  2012-10

2.  Modulation of prepulse inhibition and stereotypies in rodents: no evidence for antipsychotic-like properties of histamine H3-receptor inverse agonists.

Authors:  Aude Burban; Chit Sadakhom; Dominique Dumoulin; Christiane Rose; Gwenaëlle Le Pen; Henriette Frances; Jean-Michel Arrang
Journal:  Psychopharmacology (Berl)       Date:  2010-05-01       Impact factor: 4.530

3.  The expression and function of histamine H₃ receptors in pancreatic beta cells.

Authors:  T Nakamura; T Yoshikawa; N Noguchi; A Sugawara; A Kasajima; H Sasano; K Yanai
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 4.  Histamine receptors and cancer pharmacology: an update.

Authors:  Noelia A Massari; Melisa B Nicoud; Vanina A Medina
Journal:  Br J Pharmacol       Date:  2018-12-13       Impact factor: 8.739

Review 5.  Histamine receptors and cancer pharmacology.

Authors:  Vanina A Medina; Elena S Rivera
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

6.  Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition.

Authors:  Jia-Ji Lin; Tian-Zhi Zhao; Wen-Ke Cai; Yong-Xiang Yang; Chao Sun; Zhuo Zhang; Yu-Qiao Xu; Ting Chang; Zhu-Yi Li
Journal:  Oncotarget       Date:  2015-07-10

7.  Histamine H3 Receptor Promotes Cell Survival via Regulating PKA/CREB/CDKN1A Signal Pathway in Hepatocellular Carcinoma.

Authors:  Chunle Zhang; Yang Yu; Liang Ma; Ping Fu
Journal:  Onco Targets Ther       Date:  2020-05-04       Impact factor: 4.147

8.  Histamine induces proliferation in keratinocytes from patients with atopic dermatitis through the histamine 4 receptor.

Authors:  Franziska Glatzer; Maria Gschwandtner; Sarah Ehling; Kristine Rossbach; Katrin Janik; Andreas Klos; Wolfgang Bäumer; Manfred Kietzmann; Thomas Werfel; Ralf Gutzmer
Journal:  J Allergy Clin Immunol       Date:  2013-08-09       Impact factor: 10.793

9.  Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K/Akt/mTOR and MEK/ERK signaling pathways and blocking EMT.

Authors:  Yan-Yan Zhao; Jing Jia; Jing-Jing Zhang; Yan-Ping Xun; Shu-Jun Xie; Jia-Feng Liang; Hong-Gang Guo; Jia-Zhen Zhu; Sheng-Lin Ma; Shi-Rong Zhang
Journal:  Acta Pharmacol Sin       Date:  2020-11-06       Impact factor: 7.169

10.  Inhibition of histamine receptor H3R suppresses prostate cancer growth, invasion and increases apoptosis via the AR pathway.

Authors:  Jun Chen; Xiao-Yong Hu
Journal:  Oncol Lett       Date:  2018-08-16       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.